QST Hospital (National Institutes for Quantum Science and Technology)
The world's first carbon-ion therapy hospital (HIMAC, 1994), which established the clinical evidence base for heavy-ion radiotherapy.
Overview
QST Hospital, formerly the National Institute of Radiological Sciences hospital, began treating patients with carbon ions at the Heavy Ion Medical Accelerator in Chiba (HIMAC) in 1994, the first dedicated medical heavy-ion facility. Over three decades it has treated more carbon-ion patients than any other centre, developed hypofractionated protocols for prostate, lung, liver, pancreatic, bone and soft-tissue sarcoma and head and neck tumours, and pioneered scanning beam delivery, respiratory gating and the rotating gantry now used in newer facilities. The institute leads Japan's quantum-scanning carbon-ion programme, radiopharmaceutical research including astatine-211 targeted alpha therapy, and international training for centres in Europe and Asia.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to QST Hospital, including child institutions. 16 works · 110 citations · 69% open access · 0% clinical trials · 0% reviews.
- Hirotoshi Takiyama9 works
- Shigeru Yamada5 works
- Makoto Shinoto5 works
- Tetsuro Isozaki3 works
- Takayuki Ohguri2 works
- Tatsuya Ohno2 works
- Tomoaki Okimoto2 works
- Yoshiyuki Shioyama2 works
- Masanori Someya2 works
- Nobuteru Kubo2 works
- Carbon-ion therapy (HIMAC)
- Compact carbon-ion technology
- Astatine-211 alpha therapy
- Radiation biology
Similar pages
not linked directly; found by shared links- TechnologyAstatine-211 alpha therapy
Shares Astatine-211, Targeted alpha therapy, Prostate cancer.
- InstitutionOslo University Hospital, The Norwegian Radium Hospital
Shares Alpha vs beta emitters, Targeted alpha therapy, Prostate cancer.
- InstitutionChinese PLA General Hospital
Shares Hepatocellular carcinoma, Prostate cancer.
- IdeaFund alpha emitters beyond actinium-225: lead-212, terbium-149 and astatine-211
Shares Astatine-211, Alpha vs beta emitters, Targeted alpha therapy.
- IdeaAlpha-emitting PSMA therapy at first metastatic diagnosis
Shares Alpha vs beta emitters, Targeted alpha therapy, Prostate cancer.
- CompanyIONETIX
Shares Astatine-211, Targeted alpha therapy.
- CompanyAlpha Tau Medical
Shares Targeted alpha therapy, Prostate cancer.
- TermRelative biological effectiveness (RBE)